Tianjin Institute of Pharmaceutical Research Pharmaceutical Co., Ltd

Company Profile
Tianjin Institute of Pharmaceutical Research Pharmaceutical Co., Ltd
Tianjin Institute of Pharmaceutical Research Co., Ltd.was founded in 1959, it is one of the national comprehensive pharmaceutical research units directly under the former National Medical Administration. In 2000, it was restructured and entered the state-owned assets system of Tianjin. In 2018, it passed the mixed ownership reform of state-owned enterprises and became a modern research and development pharmaceutical enterprise under the China Merchants Group. The company has multiple research and development and production manufacturers of APIs. The main APIs products of the company include: Gliquidone, Glipizide, Minoxidil, Febuxostat, Procaterol Hydrochloride, Tenofovir Alafenamide Fumarate, Peramivir, Relugolix, etc.
more >

Year of Establishment:

Total Assets(USD):

Total Number of Staff:

Main Competitive Advantages:

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    Tianjin Institute of Pharmaceutical Research Pharmaceutical Co., Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service